Preliminary Presentations

 

Click here to download Preliminary List of Scientific Presentations as a pdf.
(updated March 20, 2015)

 

Preliminary List of Scientific Presentations
(Arranged alphabetically according to invited speaker)

 

Strategies to Decrease Bleeding in the Cardiac Cath Lab
Mazen S. Abu-Fadel, University of Oklahoma HScC, Oklahoma City, OK, USA

Reduction of 30-Day All-Cause Readmission in Heart Failure: Current Evidence and Future Directions
Ali Ahmed, The Washington DC VA Medical Center. Washington, DC, USA

Usefulness of Optical Coherence Tomography in Daily Clinical Practice
Takashi Akasaka, Wakayama Medical University, Wakayama, Japan

Cognitive Impairment in Chronic Heart Failure
Kannayiram Alagiakrishnan, University of Alberta, Edmonton, Alberta, Canada

The Role of Statins in the Prevention of Contrast-induced Acute Kidney Injury
Martin A. Alpert, University of Missouri- Columbia School of Medicine, Columbia, MO, USA

Advances in Cardiac Imaging for the Evaluation of Nonischemic Cardiomyopathies
Aman M. Amanullah, Albert Einstein Medical Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA

Contemporary Management of Low Risk Patients Presenting to the ED with Chest Pain
Ezra A. Amsterdam, University of California, Davis Medical Center, Sacramento, CA, USA

GI Protein as Potential Target for the Treatment of Hypertension
Madhu B. Anand-Srivastava, Faculty of Medicine, University of Montreal, Montreal,QC, Canada

Myocardial Interstitial Dissarray and Cardiovascular Apoptosis and Remodelling In Pulmonary Hypertention Dyspnea, Complicated with Late Infection
Nestor Angomachalelis, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece

Reduction in Heart Failure Readmission Rates: How low can we go? 
Juan M. Aranda Jr, University of Florida, Gainesville, FL, USA

Resistant Hypertension: Diagnostic and Treatment Issues
Diana E. Ayala, Campus Universitario Vigo, Pontevedra, Spain

Statin Intolerance - Mechanisms, Risk Factors, Definition and Management
Maciej Banach, Medical University of Lodz, Lodz, Poland 

Stent and Non-Stent Infrainguinal Peripheral Artery Revascularization: Insights From The Multicenter Xlpad Registry
S. Banerjee, VA North Texas Health Care System, Dallas, TX; University of Texas Southwestern Medical Center, Dallas, TX, USA

Gender Differences and Healthy Aging
Elizabeth Barrett-Connor, University of California, San Diego, La Jolla, CA, USA

Choosing Wisely: What Works and What Doesn't
Gregory Barsness, Mayo Clinic, Rochester, MN, USA

Genetic Epidemiology of Left Ventricular Hypertrophy
Jonathan N. Bella, Bronx-Lebanon Hospital Center, Bronx, NY, USA

Arrhythmias in Adult Congenital Heart Disease
Charles I. Berul, Children's National Health System, George Washington University,
Washington, DC, USA

Ticagrelor Ameliorates Reperfusion Injury and Improves Remodeling after Myocardial Infarction
Yochai Birnbaum, Baylor College of Medicine, Houston, TX, USA

The Role of Pharmacological Therapy in Heart Valve Diseases
Jeffrey S. Borer, State University of New York Downstate Medical Center, New York, NY, USA

eNOS and NOX Isoforms in Aortic Aneurysm Formation
Hua Linda Cai, UCLA David Geffen School of Medicine, Los Angeles, CA, USA

The 2014 AF Guidelines: What's New?
Michael E. Cain, University at Buffalo, Buffalo, NY, USA

Management of Asymptomatic Aortic Stenosis: What is new in 2015?
Hari P. Chaliki, Mayo Clinic, Arizona, USA

Do Pelvic Vascular Bed Calcifications Correlate to Coronary Artery Calcification in Modern American Population?
Yzhar Charuzi, Cedars Sinai Heart Institute, Los Angeles, CA, USA

Evolving Understanding of Stress Cardiomyopathy
Anand Chockalingam, University of Missouri – Columbia, Columbia, MO, USA

The Role of Right Ventricle on the Clinical Course of Heart Failure
Christina Chrysohoou, Hippokration Hospital, University of Athens, Athens, Greece

Statin Therapy in Older Patients
Shorena Chumburidze, David Tvildiani Medical University, Tbilisi, Rep. of Georgia

Role of Stress Ehocardiography in the Cardiac Resynchronization Therapy
Quirino Ciampi, Fatebenefratelli Hospital, Benevento, Italy

Left Ventricular Reverse Remodeling with Biventricular versus Right Ventricular Pacing in Patients with Atrioventricular Block and Left Heart Failure in the BLOCK HF Trial
Anne B. Curtis, University at Buffalo, Buffalo, NY, USA

Selectin- E in Heart Failure of Different Etiology
Sergio Dalla Volta, UniversitadegliStudi di Padova, Padova, Italy

Left Ventricular vs. Biventricular Mechanical Support for Failing Hearts: Main Challenges before Decision Making
Michael Dandel, DeutschesHerzzentrum, Berlin, Germany

Combined Angiotensin Receptor Antagonism/Neutral Endopeptidase Inhibition in Diabetes: Focus on Blood Pressure and the Kidney
Alexander H.J. Danser, Erasmus Medical Center, Rotterdam, The Netherlands

Asymptomatic Complications of Atrial Fibrillation Ablation: Fear or Not?
Thomas Deneke, University of Bochum, Germany

Genetics of Diastolic and Systolic Heart Failure
Alan Y. Deng, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada 

CO2-Bath as a Novel Therapy for Peripheral Vascular Disease
Naranjan S. Dhalla, St. Boniface Hospital Research Centre, Winnipeg, MB, Canada

Association of Modifiable Lifestyle Factors and Risk of Total and Cardiovascular Mortality among Older US Male Physicians
Luc Djousse, Brigham and Women's Hospital, Boston, MA, USA

Mendelian Randomization Studies in Cardiometabolic Medicine
Heinz Drexel, Academic Teaching Hospital Feldkirch, Feldkirch, Austria

Role of Mitochondrial Oxidative Stress in Glucose Tolerance, Insulin Resistance, and Cardiac Diastolic Dysfunction
Samuel C. Dudley, The Miriam and Rhode Island Hospitals, Providence, RI, USA

Whole Exome Sequencing for Thoracic Aortic Aneurysm: The Future is Here
John A. Elefteriades, Yale University School of Medicine, New Haven, CT, USA

Assessment of Cardiovascular Prognosis in Diabetic Patients. The Role of Cardiac Imaging
Abdou Elhendy, Marshfield Clinic, Marshfield, WI, USA

Extracellular Vesicles as New Functional Players and Potential Biomarkers in Cardiac Patients
Costanza Emanueli, Bristol Heart Institute, University of Bristol, Bristol, UK

A Large Pragmatic Trial of Statin Therapy in Primary Prevention Patients: The Next Frontier
Michael Farkouh, Toronto General Hospital, Toronto, Ontario, Canada

C-reactive Protein and Acute Coronary Artery Disease
Janos G. Filep, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada

The Secret Supremacy of Small Blood Vessels, an Enduring Puzzle of The Cardiovascular System: Research Gaps and Opportunities
Zorina Galis, NIH, Bethesda, MD, USA

Exercise Improves Vascular Insulin Sensitivity: Role of Mitochondria-ROS
Feng Gao, The Fourth Military Medical University, Xi’an, China

Safety and Efficacy of XperSwing Dual-Axis Rotational Coronary Angiography
Joel A. Garcia, Orlando Health, FL, USA

Cardioprotective Effects of Therapeutic T3 Treatment in Myocardial Infarction and Reperfusion
A. Martin Gerdes, New York Institute of Technology, Old Westbury, NY, USA

What Diabetes Mellitus has Taught us about Potential Treatments for Small Abdominal Aortic Aneurysms
S. David Gertz, The Hebrew University of Jerusalem, Jerusalem, Israel

Genetic Based Molecular Subtypes of Human Atrial Fibrillation
Michael H. Gollob, Toronto General Hospital, Toronto, Ontario, Canada

Alterations of Macrophage GSH/GSSG Status Regulate CD36 Expression and Foam Cell Formation: Implication of GSH-Antioxidant System in Atherosclerosis
Jihong Han, Nankai University, China

Interventions Using of the Electronic Medical Record to Improve Care of Patients with Heart Disease
Paul A. Heidenreich, Palo Alto VA Health Care System, Stanford University, Palo Alto, CA, USA

Treatment of Arterial Aneurysms with the Multilayer Flow Modulator Stent
Michel Henry, Bofferdange, Luxembourg

New Outcomes-Based Recommendations for Improving Hypertension Diagnosis and Treatment to Reduce Risk of Vascular Events
Ramon C. Hermida, Campus Universitario, Vigo, Pontevedra, Spain

Postcardiotomy Syndrome: Prevention and Management
Brian Hoit, Case Western Reserve University, Cleveland, OH, USA

Clinical Implications of OCT-Based Neointimal Tissue Characterization
Myeong-Ki Hong, Severance Cardiovascular Center and Severance Biomedical Science Institute, Seoul, South Korea

Targeting Molecular Pathways in Diabetes Associated Cardiovascular Disease
Mansoor Husain, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada

From Mice to Men: Expression of the novel SLRP Podocan and Wnt-Pathway effector molecules in Clinical CAD
Randolph Hutter, Mount Sinai Medical Center, New York, NY, USA

Coronary Artery Perforation-the Bane of an Interventional Cardiologist
Deepak Jain, University Clinic Schleswig-Holstein, Lubeck, Germany

Cardiovascular Responses to Threatful Challenges in Persons with High Trait Anxiety
Daniela Jezova, Slovak Academy of Sciences, Bratislava, Slovakia

Beyond the Guidelines - New Options for Treating Heart Failure in 2015
Maryl R. Johnson, University of Wisconsin-Madison, Madison, WI, USA

Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI
Erik Jorgensen, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Aging, Extracellular Matrix and Heart Failure
Bodh I. Jugdutt, University of Alberta and Hospitals, Edmonton, Alberta, Canada

Adjudicated versus Administrative Heart Failure with Preserved Ejection Fraction
Andreas Kalogeropoulos, Emory University School of Medicine, Atlanta, GA, USA 

Trans-Ulnar Interventions: Technique, Feasibility & Safety
Edo Kaluski, University Hospital, Newark, NJ, USA

Ultrafiltration Therapy for Acute Heart Failure; Where are we standing in 2015?
Amir Kazory, University of Florida, Gainesville, FL, USA

Point of Care Ultrasound: The New Physical Examination
llan Kedan, Cedars Sinai Medical Group, Beverly Hills, CA, USA

LV Non Compaction: State of the Art 2015
Bijoy Khandheria, University of Wisconsin School of Medicine and Public Health, Milwaukee, WI, USA

Hybrid Atrial Fibrillation for Advanced Atrial Fibrillation
Ali Khoynezhad, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Regulation of Cell Death Signaling Pathways in the Heart
Lorrie A. Kirshenbaum, St. Boniface Research Centre, Winnipeg, Manitoba, Canada

Body Mass Index and Mortality: Is it Really Healthier to be Overweight?
Arthur L. Klatsky, Kaiser Permanente Medical Center, Oakland, CA, USA

Aging, Senescence and the Endothelial Cell
Anne A. Knowlton, University of California, Davis, CA, USA

PCS K9 Inhibitors in Statin Intolerant Patients: Option for the future? 
Stephen L. Kopecky, Mayo Clinic, Rochester, MN, USA

The Use of Appropriate Use Criteria for Cardiac Imaging
Smadar Kort, Stony Brook Medicine - Stony Brook University, Stony Brook, NY, USA

Conventional and Novel Intravascular Imaging Techniques
Santhosh K.G. Koshy, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA

PDE5 Inhibition in Cardioprotection
Rakesh C. Kukreja,Virginia Commonwealth University, Richmond, VA, USA

Role of COQ10 as Adjunctive Therapy in Congestive Heart Failure
Adarsh Kumar, Govt. Medical College/G.N.D. Hospital, Amritsar, India

Coronary Vasomotor Regulation by CRP and LOX
Lih Kuo, Texas A&M Health Science Center, Temple, TX, USA

Mitochondrial Quality Control in Type 1 Diabetic Heart
Qiangrong Liang, New York Institute of Technology, Old Westbury, NY, USA

Altered Nuclear and Cytoskeletal Mechanics in Cardiac Myocytes with D192G Nuclear Lamin Mutation
Carlin S. Long, University of Colorado Health Sciences Center, Denver, CO, USA

Inhibition of Pyruvate Dehydrogenase Kinase Decreases the Severity of Heart Failure Associated with Obesity
Gary Lopaschuk, University of Alberta, Edmonton, Alberta, Canada

Atherosclerosis, Cancer and Wound Healing; The Systems Biology Connection
Alexandra Lucas, University of Florida, Gainesville, FL, USA

Predicting Long-term Outcome in Asymptomatic and Low-Risk Symptomatic Patients: Implications for Cardiac Testing in a Multimodality Imaging World
John J. Mahmarian, Weill Cornell Medical College, Methodist DeBakey Heart Center, Houston, TX, USA

Navigating the Complexities of Apoptosis and Autophagy in Cardiovascular Disease: Can We Chart a Clear Course?
Kenneth Maiese, University of Medicine & Dentistry of New Jersey, Newark, NJ, USA

New Insights into Sex-Based Differences in Heart Disease
Shaista Malik, University of California, Irvine, Orange, CA, USA

Early Diagnosis of the Cardiovascular System - The Nanomedical Evaluation of Endothelial Dysfunction
Tadeusz Malinski, Ohio University, Athens, OH, USA

Time of Onset of Cardiac Events: Does Gender Matter?
Roberto Manfredini, University of Ferrara, Italy

Adult Congenital Heart Disease
Ariane Marelli, McGill University Health Centre, Montreal, QC, Canada

Inflammation in Atherosclerosis- Revisited
Jawahar L. Mehta, University of Arkansas for Medical Sciences, Little Rock, AR, USA 

Update on Treatment of Valve Disease in Elderly Patients
Issam Mikati, Feinberg School of Medicine, Chicago, IL, USA

Stem Cell and Gene Therapy: The Future of CV Medicine
Leslie W. Miller, University of South Florida, Tampa, FL, USA

Non-Pharmacologic Approaches to Secondary Prevention of CVD-Evidence Based Improvements in Outcomes
Freny Vaghaiwalla Mody, VA Greater Los Angeles Healthcare System, LA, USA

Novel Biomarkers of Lipid and Lipoprotein Metabolism
Samia Mora, Brigham and Women's Hospital, Boston, MA, USA

Respiratory Maneuvers That Can Be Useful During Cardiac Cauterization or Coronary Interventions
Mohammad-Reza Movahed, The Southern Arizona VA Health Care System, Tucson, AZ, USA

Determinants of Cardiac Function in patients with Dilated Cardiomyopathy
Sherif F. Nagueh, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA

The role of microRNAS in Peripartum Cardiomyopathy
Nandini Nair, Spokane Heart Institute, Spokane,WA, USA

CAC testing in 2015: Role in Shared Decision Making?
Khurram Nasir, Center for Wellness and Prevention Baptist Health South Florida, Miami Beach, FL, USA

Regulation of Intestinal Genes by an Oral Peptide Reduces Systemic Inflammation and Reduces Atherogenesis
Mohamad Navab, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Mediterranean Diet: From History to Culture to Medicine
Demosthenes B. Panagiotakos, Harokopio University, Athens, Greece

Postinfarct VSD: Operate or Wait? 
Louis P. Perrault, Montreal Heart Institute, Montreal, QC, Canada

Noninvasive Assessment of Myocardial Stiffness by Ultrasound
Cristina Pislaru, Mayo Clinic, Rochester, MN, USA

Misconceptions and Diagnostic Challenges in Bioprosthetic Valve Thrombosis
Sorin Pislaru, Mayo Clinic College of Medicine, Rochester, MN, USA     

The Management of Patients with Advanced Heart Failure
Maria Vittoria H. Pitzalis, East Carolina University, The Brody School of Medicine, Greenville, NC, USA

Role of Reactive Oxygen Species in the Added Sugar-Induced Cardiovascular Disease
Kailash Prasad, University of Saskatchewan, Saskatoon, SK, Canada

Exercise Echocardiography: Advantages and Disadvantages
Maria Prokudina, Federal Center of Heart, Blood and Endocrinology, St. Petersburg, Russia

Aspirin-Insensitive Thromboxane Generation as a Marker of Endothelial Dysfunction
Jeffrey J. Rade, UMASS Medical School, Worcester, MA, USA

Targeting of Angiotensin Converting Enzyme 2 for Cardio-Pulmonary Diseases
Mohan K. Raizada, University of Florida, Gainesville, FL, USA 

The Ldl density radius theory:A subanalysis of The SEAS trial
Nalini M. Rajamannan, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Diagnostic Tricks and Timely Treatment of Aortic Intramural Hematoma
Hanumanth K. Reddy, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Genetics of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease      
Robert S. Rosenson, Icahn School of Medicine at Mount Sinai,  New York, NY, USA

Bendavia (MTP-131), a Mitochondria Targeting Peptide, Normalizes Dysregulation of Mitochondria Fission and Fusion Proteins in Myocardium of Dogs with Chronic Heart Failure
Hani N. Sabbah, Henry Ford Heart & Vascular Institute, Detroit, MI, USA

Transcatheter Closure of ASD with Pulmonary Hypertension
Masood Sadiq, The Children's Hospital/ Institute of Child Health, Lahore. Pakistan

Familial hypercholesterolemia: Whom to screen? How to treat?
Christoph H. Saely, Academic Teaching Hospital Feldkirch, Feldkirch, Austria

How does imaging help in indication for early surgery for Mitral Regurgitation?
Maurice E. Sarano, Mayo Clinic, Rochester, MN, USA

Cardiovascular Effects of Carfilzomib, a New Proteasome Inhibitor, on Coronary Resistance, Vascular Tone and Vascular Reactivity
Tiziano M. Scarabelli, St John Hospital & Medical Center/Wayne State University, MI, USA

Global Atrial Fibrillation Burden: Prevention rather Treatment must be the Goal!
Karlheinz Seidl, Klinikum Ingolstadt GmbH, Ingolstadt, Germany

Evolving Role of Platelet Function Testing In Acute Coronary Syndromes
Rakesh Sharma, University of Arkansas Medical Science, USA

Pro-Inflammatory and Anti-Inflammatory Mast Cells in Obesity and Diabetes
Guo-Ping Shi, Brigham and Women's Hospital, Boston, MA, USA

Myocardial Viability in Coronary Artery Chronic Total Occlusion
Jamshid Shirani, St. Luke's Hospital and Health Network, Bethlehem, PA, USA

Stable Ischemic Heart Disease: The Present and The Future
Mandeep S. Sidhu, Albany Medical Center, Albany, NY, USA

The Heart Failure Clinic: Taking Center Stage in Chronic Disease Management
Marc A. Silver, University of Illinois, Advocate Christ Medical Center, South Oak Lawn, IL, USA

Innate Signaling in Heart Disease
Pawan K. Singal, St. Boniface Hospital Research Centre, Winnipeg, MB, Canada

Inflammation in Heart Diseases
Dinender K.Singla, University of Central Florida, Orlando, FL, USA

Syncope vs Psuedosyncope: Differentiation, Diagnosis and Treatment
Christopher S. Snyder, Rainbow Babies and Children's Hospital, Cleveland, OH, USA

Computed Tomography Coronary Angiography: Diagnostic and Prognostic Value
Fabiola Sozzi, Ospedale Maggiore Policlinico di Milano, Italy

Cholesterol Goals & Targets: Should we IMPROVE-IT
Laurence Sperling, Emory University School of Medicine, Atlanta, GA, USA

Viewing Heart Failure as Interstitial Cancer - Diagnostic and Therapeutic Avenues
Francis Spinale, USC School of Medicine, Columbia, SC, USA

Success of Atrial Fibrillation Ablation in Various Subsets
Komandoor Srivathsan, Mayo Clinic, AZ, USA

Role of Early Growth Response Protein-1 (Egr-1) in Vascular Biology
Ashok K. Srivastava, Centre Hospitalier de l' Universite de Montreal,Montreal, QC, Canada

Bone Marrow Stem Cells in Ischemic Heart Disease
Gustav Steinhoff, University of Rostock, Germany

Cardiac Fibrosis in Heart Failure
Andrew J. Taylor, BakerIDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia

Endothelial Dysfunction after Percutaneous Coronary Interventions and Medical Therapies
Mitsuyasu Terashima, Toyohashi Heart Center, Toyohashi, Aichi, Japan

Management of Ischemic Heart Disease: Update 2015
Udho Thadani, University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, OK, USA

Strategies for Prevention of Cardiovascular Events in Patients with Polyvascular Disease
Takanobu Tomaru, Toho University, Sakura Hospital, Japan

Calcium Signaling, Transcription and DCM
Balwant S. Tuana, University of Ottawa, Ottawa, ON, Canada

Non-coding RNAs, New Players in the Heart
Da-Zhi Wang, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA

Transcatheter Valve Implantation; Aortic and Mitral
John Webb, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada

The ACC/AHA Prevention of Cardiovascular Disease Guidelines: 2015 Update
Nathan D. Wong, University of California, Irvine, Irvine, CA, USA

Vascular Resident Stem Cells in Arteriosclerosis
Qingbo Xu, Kings College London, London, UK

FIM Transcatheter Mitral Valve Replacement for Native Mitral Valve Regurgitation
Jian (James) Ye, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada

Dilating Vascular Disease: A Systematic Approach to Pathophysiology
Ertan Yetkin, International Medical Center, Mercin, Turkey

Unique Role of Echo and TEE in New Structural Heart Disease Intervention
Cheuk-Man Yu, The Chinese University of Hong Kong, Hong Kong

Role of Cilia in Congenital Heart Disease
Maliha Zahid, University of Pittsburgh, Pittsburgh, PA, USA

Zhang's Phenomenon (His ElectrogramAlternans) and a New Model of Atrioventricular Node Dual Pathway Conduction
Youhua Zhang, New York Institute of Technology (NYIT), Old Westbury, NY, USA

Regulation of Myocardin Activity in Vascular Smooth Muscle
Xi-Long Zheng, Libin Cardiovascular Inst., The University of Calgary, Canada 

 

Affiliated with


 

    international academy of cardiology

 IACS